{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:13:14Z","timestamp":1784628794656,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05993-y","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:50:52Z","timestamp":1755910252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Access to pediatric oncology medicine in Iran: a cross-sectional survey in Urmia"],"prefix":"10.1186","volume":"25","author":[{"given":"Kiana","family":"Baghban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadra Nadimi","family":"Parashkouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Abbasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Varmaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Noroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"5993_CR1","unstructured":"World Health Organization. CureAll framework: WHO global initiative for childhood cancer: increasing access, advancing quality, saving lives. (2021)."},{"issue":"6432","key":"5993_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1126\/science.aaw4892","volume":"363","author":"CG Lam","year":"2019","unstructured":"Lam CG, Howard SC, Bouffet E, Pritchard-Jones K. Science and health for all children with cancer. Science. 2019;363(6432):1182\u20136.","journal-title":"Science"},{"key":"5993_CR3","volume-title":"Closing the cancer divide: a blueprint to expand access in low- and middle-income countries","author":"FM Knaul","year":"2011","unstructured":"Knaul FM, Frenk J, Shulman L. Closing the cancer divide: a blueprint to expand access in low- and middle-income countries. Boston, MA: Harvard Global Equity Initiative; 2011."},{"key":"5993_CR4","unstructured":"World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. (2020)."},{"key":"5993_CR5","unstructured":"World Health Organization. Global initiative for childhood cancer. (2018). Available from: https:\/\/www.who.int\/news-room\/detail\/04-10-2018-global-initiative-for-childhood-cancer"},{"key":"5993_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/2050312117738691","volume":"5","author":"R Shrestha","year":"2017","unstructured":"Shrestha R, Ghale A, Chapagain BR, Gyawali M, Acharya T. Survey on the availability, price and affordability of selected essential medicines for non-communicable diseases in community pharmacies of Kathmandu valley. SAGE Open Med. 2017;5: 2050312117738691.","journal-title":"SAGE Open Med"},{"key":"5993_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fpubh.2021.628744","volume":"9","author":"P Ocran Mattila","year":"2021","unstructured":"Ocran Mattila P, Ahmad R, Hasan SS, Babar Z-U-D. Availability, affordability, access, and pricing of anti-cancer medicines in low- and middle-income countries: a systematic review of literature. Front Public Health. 2021;9:462.","journal-title":"Front Public Health"},{"issue":"1","key":"5993_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08435-x","volume":"21","author":"KB Mensah","year":"2021","unstructured":"Mensah KB, Mensah ABB, Bangalee V, Padayachee N, Oosthuizen F. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana. BMC Cancer. 2021;21(1): 683.","journal-title":"BMC Cancer"},{"key":"5993_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16193728","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Wang Y, Sun X, Li X. Availability, price and affordability of anticancer medicines: evidence from two cross-sectional surveys in the Jiangsu province, China. Int J Environ Res Public Health. 2019. https:\/\/doi.org\/10.3390\/ijerph16193728.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"5993_CR10","first-page":"193","volume":"9","author":"S Hassanipour","year":"2019","unstructured":"Hassanipour S, Fathalipour M, Delam H, Ghorbani M, Abdzadeh E, Arab-Zozani M, et al. The incidence of childhood cancer in iran: a systematic review and meta-analysis. Iran J Pediatr Hematol Oncol. 2019;9(3):193\u2013206.","journal-title":"Iran J Pediatr Hematol Oncol"},{"issue":"8","key":"5993_CR11","first-page":"1145","volume":"46","author":"S Khazaei","year":"2017","unstructured":"Khazaei S, Khazaei S, Mansori K, Ayubi E. Childhood cancer patterns in iran: challenges and future directions. Iran J Public Health. 2017;46(8):1145\u20136.","journal-title":"Iran J Public Health"},{"issue":"3","key":"5993_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.26719\/2004.10.3.406","volume":"10","author":"A Cheraghali","year":"2004","unstructured":"Cheraghali A, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. EMHJ - Eastern Mediterranean Health Journal. 2004;10(3):406\u201315.","journal-title":"EMHJ - Eastern Mediterranean Health Journal"},{"issue":"7","key":"5993_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.26719\/emhj.18.068","volume":"25","author":"E Heidari","year":"2019","unstructured":"Heidari E, Varmaghani M, Abdollahiasl A. Availability, pricing and affordability of selected medicines for noncommunicable diseases. East Mediterr Health J. 2019;25(7):473\u201380.","journal-title":"East Mediterr Health J"},{"key":"5993_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40545-020-00245-z","volume":"13","author":"S Zartab","year":"2020","unstructured":"Zartab S, Koopaei NN, Abbasian H, Koopaei MN. The impact of sanctions and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001\u20132016. J Pharm Policy Pract. 2020;13:1\u20139.","journal-title":"J Pharm Policy Pract"},{"issue":"3","key":"5993_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.34172\/PS.2020.93","volume":"27","author":"H Abbasian","year":"2020","unstructured":"Abbasian H, Yousefi-Zenouz R, Abdollahiasl A, Toroski M, Nikfar S, Siahi-Shadbad M, et al. Risk factors of supply chain in biopharmaceutical companies in Iran. Pharm Sci. 2020;27(3):439\u201349.","journal-title":"Pharm Sci"},{"key":"5993_CR16","unstructured":"United Nations. Orumiyeh, Iran Metro Area Population 1950\u20132025. World Population Prospects. (2022). Available from: https:\/\/www.macrotrends.net\/global-metrics\/cities\/21511\/orumiyeh\/population"},{"issue":"4","key":"5993_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00004703-198808000-00011","volume":"9","author":"RE Behrman","year":"1988","unstructured":"Behrman RE, Vaughan VC. Nelson textbook of pediatrics. J Dev Behav Pediatr. 1988;9(4):239\u201343.","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"5993_CR18","volume":"31","author":"M Varmaghani","year":"2023","unstructured":"Varmaghani M, Elyasi S, Mojahedian MM, Ghavami V, Borhani B, Javan-Noughabi J, et al. Availability and affordability of anticancer medicines in Iran based on WHO\/HAI standard survey methods. Support Care Cancer. 2023;31(1): 89.","journal-title":"Support Care Cancer"},{"key":"5993_CR19","unstructured":"World Health Organization. Measuring medicine prices, availability, affordability and price components. (2008)."},{"key":"5993_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/B978-0-12-813166-4.00012-7","volume-title":"Medicine price surveys, analyses and comparisons","author":"PKS Raju","year":"2019","unstructured":"Raju PKS. WHO\/HAI methodology for measuring medicine prices, availability and affordability, and price components. In: Medicine price surveys, analyses and comparisons. Elsevier; 2019. p. 209\u201328."},{"key":"5993_CR21","unstructured":"Iran Food & Drug Administration. National Formulary of Iran. (2022). Available from: https:\/\/irc.fda.gov.ir\/nfi"},{"key":"5993_CR22","volume-title":"International medical products price guide","author":"Health Management Solutions","year":"2015","unstructured":"Health Management Solutions. International medical products price guide. MA, USA: MSH Medford; 2015."},{"key":"5993_CR23","unstructured":"Iran Food and Drug Organization. Official exchange rate. (2022). Available from: https:\/\/www.fda.gov.ir\/"},{"issue":"2","key":"5993_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40199-022-00454-8","volume":"30","author":"F Kokabisaghi","year":"2022","unstructured":"Kokabisaghi F, Hashemi-Meshkini A, Obewal A, Ghavami V, Javan-Noughabi J, Shabanikiya H, et al. Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020. DARU J Pharm Sci. 2022;30(2):343\u201350.","journal-title":"DARU J Pharm Sci"},{"key":"5993_CR25","unstructured":"Iran Ministry of Cooperatives, Labor, and Social Welfare. The regulation for determining the minimum wage of workers in 1401. (2022). Available from: https:\/\/www.mcls.gov.ir\/icm_content\/media\/image\/2022\/03\/527670_orig.pdf"},{"issue":"8","key":"5993_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/annonc\/mdw213","volume":"27","author":"N Cherny","year":"2016","unstructured":"Cherny N, Sullivan R, Torode J, Saar M, Eniu A. ESMO european consortium study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Ann Oncol. 2016;27(8):1423\u201343.","journal-title":"Ann Oncol"},{"issue":"Suppl","key":"5993_CR27","first-page":"64","volume":"17","author":"AV Farahani","year":"2018","unstructured":"Farahani AV, Salamzadeh J, Rasekh HR, Najafi S, Mosadegh V. The availability and affordability of cardiovascular medicines for secondary prevention in Tehran Province (Iran). Iran J Pharm Res. 2018;17(Suppl):64.","journal-title":"Iran J Pharm Res"},{"key":"5993_CR28","doi-asserted-by":"publisher","unstructured":"Faruqui N, Martiniuk A, Sharma A, Sharma C, Rathore B, Arora RS, et al. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India. BMJ Glob Health. 2019. https:\/\/doi.org\/10.1136\/bmjgh-2018-001379.","DOI":"10.1136\/bmjgh-2018-001379"},{"issue":"8","key":"5993_CR29","doi-asserted-by":"publisher","first-page":"e051465","DOI":"10.1136\/bmjopen-2021-051465","volume":"11","author":"HTT Nguyen","year":"2021","unstructured":"Nguyen HTT. Access to essential medicines for children: a cross-sectional survey measuring medicine prices, availability and affordability in Hanam Province. Vietnam BMJ Open. 2021;11(8):e051465.","journal-title":"Vietnam BMJ Open"},{"issue":"42","key":"5993_CR30","doi-asserted-by":"publisher","first-page":"71548","DOI":"10.18632\/oncotarget.17742","volume":"8","author":"DA Goldstein","year":"2017","unstructured":"Goldstein DA, Clark J, Tu Y, Zhang J, Fang F, Goldstein R, et al. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget. 2017;8(42):71548.","journal-title":"Oncotarget"},{"key":"5993_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3888-y","volume":"17","author":"S Salmasi","year":"2017","unstructured":"Salmasi S, Lee KS, Ming LC, Neoh CF, Elrggal ME, Babar, Z-U-D, et al. Pricing appraisal of anti-cancer drugs in the Southeast asian, Western Pacific and East mediterranean region. BMC Cancer. 2017;17:1\u201311.","journal-title":"BMC Cancer"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05993-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:07:59Z","timestamp":1757416079000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05993-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5993"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05993-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was confirmed by the Ethics Committee of Urmia University of Medical Sciences (UMSU): IR.UMSU.REC.1401.260. Informed consent to participate was obtained from the parents or legal guardians of any participant under the age of 16.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"639"}}